Publications

2023

In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiency.

Annals of internal medicine.176(4):JC46-[DOI] 10.7326/J23-0013.[PMID] 37011395.

PubMed·Publisher's Site

2023

In uncontrolled T2DM treated with a basal-bolus insulin regimen, weekly icodec was noninferior to daily glargine for HbA1c at 26 wk.

Annals of internal medicine.176(8):JC94-[DOI] 10.7326/J23-0058.[PMID] 37523705.

PubMed·Publisher's Site

2022

Clinical Considerations for Insulin Therapy in Older Adults with Type 1 Diabetes.

Drugs & aging.39(1):23-37[DOI] 10.1007/s40266-021-00900-3.[PMID] 34664212.

2 citations·PubMed·Publisher's Site

2022

Management of Hyperglycemia in Older Adults with Type 2 Diabetes.

Drugs & aging.39(1):39-58[DOI] 10.1007/s40266-021-00910-1.[PMID] 34921341.

3 citations·PubMed·Publisher's Site

2021

Acute Unilateral Nonhemorrhagic Adrenal Infarction in Pregnancy.

AACE clinical case reports.7(3):228-229[DOI] 10.1016/j.aace.2020.12.015.[PMID] 34095495.

2 citations·PubMed·Publisher's Site

2021

Clavicular Metastasis as an Initial Presentation of Papillary Thyroid Cancer.

Case reports in endocrinology.2021():6662071-[DOI] 10.1155/2021/6662071.[PMID] 34484842.

1 citations·PubMed·Publisher's Site

2021

In type 2 diabetes, tirzepatide reduced HbA1c vs. semaglutide.

Annals of internal medicine.174(11):JC127-[DOI] 10.7326/ACPJ202111160-127.[PMID] 34724396.

PubMed·Publisher's Site

2020

In type 2 diabetes, some glucose-lowering drugs reduce HbA1c more than others; drugs do not differ for mortality.

Annals of internal medicine.173(10):JC53-[DOI] 10.7326/ACPJ202011170-053.[PMID] 33197350.

PubMed·Publisher's Site

2020

Symptomatic Pituitary Metastasis as Initial Manifestation of Renal Cell Carcinoma: Case Report and Review of Literature.

Case reports in endocrinology.2020():8883864-[DOI] 10.1155/2020/8883864.[PMID] 32908722.

2 citations·PubMed·Publisher's Site

2016

In type 2 diabetes treated with high-dose insulin, liraglutide reduced HBA1c.

Annals of internal medicine.165(8):JC40-[DOI] 10.7326/ACPJC-2016-165-8-040.[PMID] 27750300.

PubMed·Publisher's Site

2015

ACP Journal Club. Review: In patients with type 2 diabetes who fast, sitagliptin reduces hypoglycemia more than sulfonylurea.

Annals of internal medicine.163(8):JC8-[DOI] 10.7326/ACPJC-2015-163-8-008.[PMID] 26502145.

PubMed·Publisher's Site

2014

ACP Journal Club. Review: sodium-glucose cotransporter 2 inhibitors reduce HbA1c and weight but increase infections.

Annals of internal medicine.160(2):JC10-[DOI] 10.7326/0003-4819-160-2-201401210-02010.[PMID] 24445708.

1 citations·PubMed·Publisher's Site

2012

Treatment of hyperprolactinemia: a systematic review and meta-analysis.

Systematic reviews.1():33-[DOI] 10.1186/2046-4053-1-33.[PMID] 22828169.

60 citations·PubMed·Publisher's Site

2012

Tumor-induced osteomalacia caused by primary fibroblast growth factor 23 secreting neoplasm in axial skeleton: a case report.

Case reports in endocrinology.2012():185454-[DOI] 10.1155/2012/185454.[PMID] 23346426.

15 citations·PubMed·Publisher's Site

2011

ACP Journal Club. Review: Evidence for the effectiveness of interventions to prevent foot ulcers in patients with diabetes is limited.

Annals of internal medicine.155(8):JC4-8[DOI] 10.7326/0003-4819-155-8-201110180-02008.[PMID] 22007067.

1 citations·PubMed·Publisher's Site

2011

Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials.

Journal of diabetes science and technology.5(4):952-65[DOI] .[PMID] 21880239.

73 citations·PubMed·Publisher's Site

2009

ACP Journal Club. Intensive glucose control increased risk for death and severe hypoglycemia in critically ill adults.

Annals of internal medicine.151(4):JC2-5[DOI] .[PMID] 19687479.

PubMed·Publisher's Site

2009

ACP Journal Club. Review: Intensive insulin therapy increases risk for hypoglycemia but not mortality in critically ill adults.

Annals of internal medicine.151(4):JC2-4, JC2[DOI] .[PMID] 19687478.

2 citations·PubMed·Publisher's Site

2009

Glycemic control in the medical intensive care unit.

Journal of diabetes science and technology.3(6):1330-41[DOI] .[PMID] 20144387.

20 citations·PubMed·Publisher's Site

2009

In patients with type 2 diabetes, perindopril-indapamide had similar relative reductions in mortality and cardiac events regardless of AF status.

Evidence-based medicine.14(6):177-[DOI] 10.1136/ebm.14.6.177.[PMID] 19949179.

PubMed·Publisher's Site

2009

Incretins in the ICU: is insulin on its way out?

Critical care (London, England).13(4):161-[DOI] 10.1186/cc7913.[PMID] 19591659.

6 citations·PubMed·Publisher's Site

2008

Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta-analysis of randomized trials.7.

Mayo Clinic proceedings.83(4):418-30[DOI] .[PMID] 18380987.

56 citations·PubMed·Publisher's Site

2008

Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials.

Clinical endocrinology.69(2):244-52[DOI] 10.1111/j.1365-2265.2008.03179.x.[PMID] 18194488.

8 citations·PubMed·Publisher's Site

2008

Patient-important outcomes in registered diabetes trials.

JAMA.299(21):2543-9[DOI] 10.1001/jama.299.21.2543.[PMID] 18523223.

177 citations·PubMed·Publisher's Site

2007

Accuracy of roche accu-chek inform whole blood capillary, arterial, and venous glucose values in patients receiving intensive intravenous insulin therapy after cardiac surgery.

American journal of clinical pathology.127(6):919-26[DOI] .[PMID] 17509989.

67 citations·PubMed·Publisher's Site

2007

Endocrinopathy in POEMS syndrome: the Mayo Clinic experience.

Mayo Clinic proceedings.82(7):836-42[DOI] .[PMID] 17605964.

64 citations·PubMed·Publisher's Site

2007

Glycemic durability of monotherapy for diabetes.

The New England journal of medicine.356(13):1379-80; author reply 1380[DOI] .[PMID] 17402163.

1 citations·PubMed·Publisher's Site

2007

Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial.

Annals of internal medicine.146(4):233-43[DOI] .[PMID] 17310047.

403 citations·PubMed·Publisher's Site

2007

Patient-important outcomes in diabetes--time for consensus.

Lancet (London, England).370(9593):1104-6[DOI] .[PMID] 17905147.

38 citations·PubMed·Publisher's Site

2007

Ramipril did not reduce incident diabetes in patients with impaired glycemic control.

ACP journal club.146(1):10-[DOI] .[PMID] 17203930.

PubMed·Publisher's Site

2007

Review: ACE inhibitors and angiotensin-receptor blockers reduce diabetes in hypertension and other CV risk factors.

ACP journal club.146(1):11-[DOI] .[PMID] 17203931.

PubMed·Publisher's Site

2007

Rosiglitazone reduced type 2 diabetes but increased heart failure in patients with impaired glycemic control.

ACP journal club.146(1):8-[DOI] .[PMID] 17203928.

PubMed·Publisher's Site

2006

Temporal trends in prevalence of diabetes mellitus in a population-based cohort of incident myocardial infarction and impact of diabetes on survival.

Mayo Clinic proceedings.81(8):1034-40[DOI] .[PMID] 16901026.

24 citations·PubMed·Publisher's Site

2005

Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients.

Mayo Clinic proceedings.80(7):862-6[DOI] .[PMID] 16007890.

328 citations·PubMed·Publisher's Site

Show More